Celyad Oncology S.A. (0QFK.L) LSE

0.19

+0.006(+3.26%)

Updated at December 22 12:00PM

Currency In EUR

Valuation

Market Cap33.14M
Enterprise Value46.48M
P/E Ratio-1.16
PEG Ratio-0.07
Price/Sales Ratio43.8
Price/Book Ratio-2.43
Enterprise/Revenue44.02
Enterprise/EBITDA-1.32

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-34.83
Operating Margin-35.97

Management Effectiveness

Return On Assets-1.14
Return On Equity0.67

Income Statement

Revenue186,000
Revenue/Share0
Gross Profit919,000
EBITDA-5.39M
Net Income-5.82M
Diluted EPS-0.14

Balance Sheet

Total Cash790,000
Total Cash/Share0.02
Total Debt831,000
Total Debt/Equity-0.27
Current Ratio0.66
Book Value Per Share-0.07

Price History

52-Week Change-47.22
52-Week High1.23
52-Week Low0.19
Moving Average 50 Days0.51
Moving Average 200 Days0.6

Statistics

Average Volume1,098
Shares Outstanding27.62M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A